CROWLEY Richard 4
4 · SAVIENT PHARMACEUTICALS INC · Filed May 1, 2012
Insider Transaction Report
Form 4
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
- Sale
Common Stock, $.01 par value per share
2012-05-01$2.35/sh−9,200$21,620→ 343,800 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on April 30, 2011.